Selenium supplementation for the prevention of hepatocellular carcinomas in HBsAg positive patients (pilot study)

Mise à jour : Il y a 4 ans
Référence : ISRCTN38534743

Extrait

Not provided at time of registration


Critère d'inclusion

  • Prevention of primary liver cancer with selenium supplementation - targeted to high risk population

Liens